MOTCO’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.42K Buy
+42
New +$1.4K ﹤0.01% 557
2020
Q2
Sell
-695
Closed -$6K 734
2020
Q1
$6K Hold
695
﹤0.01% 482
2019
Q4
$7K Sell
695
-3,305
-83% -$29.5K ﹤0.01% 457
2019
Q3
$28K Buy
+4,000
New +$30.6K ﹤0.01% 360
2018
Q3
Sell
-1,000
Closed -$24K 577
2018
Q2
$24K Buy
+1,000
New +$20.4K ﹤0.01% 378
2013
Q4
Sell
-880
Closed -$33K 598
2013
Q3
$33K Hold
880
﹤0.01% 338
2013
Q2
$34K Buy
+880
New +$34.3K ﹤0.01% 341

Other funds holding TEVA

MOTCO's TEVA Position: Q2 2026 in Review

MOTCO opened a new position in Teva Pharmaceuticals (TEVA) in Q2 2026: 42 shares worth $1.42K. The stake represents ﹤0.01% of the portfolio and ranks #557 among its holdings. This is a return to the name: MOTCO previously reported a position in TEVA as recently as Q1 2020.

MOTCO first reported a position in TEVA in Q2 2013 and has held it in 7 quarters since. The position peaked at $34K in Q2 2013. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • MOTCO held 42 shares of Teva Pharmaceuticals worth $1.42K as of Q2 2026.
  • Teva Pharmaceuticals was a new MOTCO position in Q2 2026.
  • Teva Pharmaceuticals made up ﹤0.01% of MOTCO's portfolio in Q2 2026, its #557 holding.
  • MOTCO first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 7 quarters since.
  • MOTCO's Teva Pharmaceuticals position peaked at $34K in Q2 2013.
  • 676 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on MOTCO's 13F filing for Q2 2026, filed 31 Jul 2026.